Compare CHT & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHT | DXCM |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | Taiwan | United States |
| Employees | 32452 | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8B | 26.5B |
| IPO Year | 2003 | 2005 |
| Metric | CHT | DXCM |
|---|---|---|
| Price | $42.64 | $65.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 21 |
| Target Price | N/A | ★ $85.33 |
| AVG Volume (30 Days) | 192.4K | ★ 3.3M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | N/A | ★ 2.09 |
| Revenue | N/A | N/A |
| Revenue This Year | $5.39 | $14.48 |
| Revenue Next Year | $3.22 | $12.39 |
| P/E Ratio | ★ $26.66 | $30.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.28 | $54.11 |
| 52 Week High | $47.03 | $89.07 |
| Indicator | CHT | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.96 | 49.33 |
| Support Level | $41.93 | $63.72 |
| Resistance Level | $43.35 | $69.18 |
| Average True Range (ATR) | 0.96 | 1.97 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 82.92 | 63.86 |
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company's reportable segments are: Consumer Business, Enterprise Business, International Business, and Others. The majority of its revenue comes from the Consumer Business, which focuses on individual and home-centric businesses, such as mobile, fixed broadband, Wi-Fi, IPTV (MOD), and OTT services. The Enterprise business offers IDC, cloud, cybersecurity, 5G, AIoT, data, AI, enterprise digital transformation, and system integration services to businesses, and the International business segment represents services offered to international customers. Geographically, the company generates maximum revenue from its business in Taiwan.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.